Centric Names Excellence in Innovation Award Winner

Posted: Updated:

Indianapolis-based Centric Inc. has named John Lechleiter the 2017 Excellence in Innovation Award winner. Part of the Indiana Innovation Awards, the Excellence in Innovation Award recognizes an individual whose career body of work reflects continued success and innovative leadership in the state of Indiana. The winner of the Excellence in Innovation Award is selected by Centric’s board of directors.

Lechleiter joins an elite group of past winners that includes Jim McClelland, Ellen Rosenthal, Mitch Daniels, Michael Crowther and Allison Melangton. He retired as Eli Lilly and Co.'s president and chief executive officer on December 31, 2016. Lechleiter originally joined Lilly in 1979 as a senior organic chemist in process research and development and became head of that department in 1982. In 1984, he began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England. Lechleiter later held roles in project management, regulatory affairs, product development, and pharma operations. In 2005, he was named Lilly president and chief operating officer and joined the board of directors.

Lechleiter became CEO on April 1, 2008. He is credited with successfully guiding Lilly through the patent expirations for four of its main products (Gemzar, Zyprexa, Cymbalta and Evista), and for establishing a promising pipeline of possible new drugs. He continues to serve as chairman of the board of directors for Eli Lilly and Co., a position he has held since 2009.

Lechleiter is a member of the American Chemical Society and chairman of the United Way Worldwide. He also serves on the boards of the Chemical Heritage Foundation, the Central Indiana Corporate Partnership, Great Lakes Chemical Corp., Nike Inc. and Ford Motor Co. Lechleiter received the 2015 International Citizen of the Year Award from the International Center of Indianapolis and in 2014, was named as the August W. Watanabe Life Sciences Champion of the Year for his work supporting the development of the Indiana Biosciences Research Institute.

  • Perspectives

    • The Evolution of Business: From Bottom Line to Value Creation And Impact

      In today's world, consumers want to know how corporations, as a whole, are taking a stand. In fact, customers are 43 percent more likely to purchase a product from a company they know is committed to social value. It's not just consumers pushing this trend. Financial service industry leaders, like KeyBank's Beth Mooney and BlackRock's Larry Fink, are challenging business owners and the C-Suite to rethink their economic impact, environmental footprint and social conscience.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Indy Firm Taps Appirio Exec as CEO

      An Indianapolis-based design and innovation consulting firm has named a new chief executive officer. Studio Science says Steve Pruden, who most recently served as senior vice president of human resources with Indy tech company Appirio, will lead the company.

    • (Image Courtesy: Lilly Oncology)

      Lilly Closes on Mega Acquisition

      Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has completed its acquisition of ARMO BioSciences Inc. of California. The deal, which was valued at approximately $1.6 billion when first announced last month, boosts Lilly's immuno-oncology pipeline. Lilly offered $50 per share of ARMO stock for the company. ARMO's portfolio includes...

    • Court Sides With Lilly on Alimta Case

      The latest in a string of patent infringement cases involving Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has ended positively for the pharmaceutical giant. The U.S. District Court for the Southern District of Indiana has ruled in favor of Lilly, preventing a competitor from launching an alternative form of its Alimta vitamin regimen. The court ruled that Lilly's patent for Alimta would be infringed upon if India-based Dr. Reddy's Laboratories had moved forward with...

    • St. Vincent Announces Layoffs

      St. Vincent Health says it has laid off 85 employees throughout the state. In a statement to Inside INdiana Business, St. Vincent cites a rapidly-evolving healthcare environment as a reason for the workforce reduction. 

    • Pam Austin

      PNC Bank Appoints Senior VP

      PNC Bank has appointed Pamela Austin senior vice president and senior banking advisor for wealth management. She has more than 30 years of banking experience, including private banking, financial analysis, marketing, business development sales, wealth transfer and problem resolution for clients and their families. Most recently she served as vice president at 1st Source Bank.